Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Aprea Therapeutics, Inc. (APRE) had Cash Flow from Financial Activities of $34.62M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-3.29M |
|
-- |
|
-- |
|
$3.43M |
|
$-3.43M |
|
$0.14M |
|
$-3.29M |
|
$-3.29M |
|
$-3.29M |
|
$-3.29M |
|
$-3.29M |
|
$-3.29M |
|
$-3.43M |
|
$-3.42M |
|
14.69M |
|
14.69M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$47.25M |
|
$0.05M |
|
$0.37M |
|
$47.61M |
|
$5.30M |
|
-- |
|
$0.73M |
|
$6.02M |
|
$41.59M |
|
$41.59M |
|
$41.59M |
|
11.98M |
|
| Cash Flow Statement Financials | |
$-2.76M |
|
-- |
|
|
Cash Flow from Financial Activities |
$34.62M |
$14.64M |
|
$46.51M |
|
$31.87M |
|
$0.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.76M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.91% |
|
-7.91% |
|
-6.91% |
|
-7.91% |
|
$3.47 |
|
$-0.19 |
|
$-0.19 |
|